Comunicación clínica
Presencia de anticuerpos anti-SRP y anti-M2 en paciente con polimiositis severa
Presence of anti-SRP and anti-M2 antibodies in patients with severe polymyositis
Leído
18034
Vecesse ha leído el artículo
12714
Total PDF
5320
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 0 | 14 | 14 |
| 2025 5 | 0 | 110 | 110 |
| 2025 4 | 0 | 128 | 128 |
| 2025 3 | 0 | 163 | 163 |
| 2025 2 | 0 | 120 | 120 |
| 2025 1 | 0 | 152 | 152 |
| 2024 12 | 0 | 152 | 152 |
| 2024 11 | 0 | 165 | 165 |
| 2024 10 | 0 | 171 | 171 |
| 2024 9 | 0 | 208 | 208 |
| 2024 8 | 0 | 161 | 161 |
| 2024 7 | 0 | 196 | 196 |
| 2024 6 | 0 | 189 | 189 |
| 2024 5 | 0 | 189 | 189 |
| 2024 4 | 0 | 211 | 211 |
| 2024 3 | 0 | 194 | 194 |
| 2024 2 | 0 | 172 | 172 |
| 2024 1 | 0 | 154 | 154 |
| 2023 12 | 0 | 186 | 186 |
| 2023 11 | 0 | 255 | 255 |
| 2023 10 | 0 | 288 | 288 |
| 2023 9 | 0 | 235 | 235 |
| 2023 8 | 0 | 226 | 226 |
| 2023 7 | 0 | 252 | 252 |
| 2023 6 | 0 | 219 | 219 |
| 2023 5 | 0 | 208 | 208 |
| 2023 4 | 0 | 183 | 183 |
| 2023 3 | 11 | 147 | 158 |
| 2023 2 | 0 | 144 | 144 |
| 2022 1 | 0 | 87 | 87 |
| 2022 12 | 0 | 102 | 102 |
| 2022 11 | 0 | 114 | 114 |
| 2022 10 | 0 | 102 | 102 |
| 2022 9 | 0 | 93 | 93 |
| 2022 8 | 0 | 103 | 103 |
| 2022 7 | 0 | 117 | 117 |
| 2022 6 | 0 | 139 | 139 |
| 2022 5 | 0 | 119 | 119 |
| 2022 4 | 0 | 97 | 97 |
| 2022 3 | 0 | 179 | 179 |
| 2022 2 | 0 | 93 | 93 |
| 2021 1 | 0 | 163 | 163 |
| 2021 12 | 0 | 131 | 131 |
| 2021 11 | 0 | 124 | 124 |
| 2021 10 | 0 | 165 | 165 |
| 2021 9 | 0 | 152 | 152 |
| 2021 8 | 0 | 136 | 136 |
| 2021 7 | 0 | 131 | 131 |
| 2021 6 | 0 | 167 | 167 |
| 2021 5 | 0 | 170 | 170 |
| 2021 4 | 0 | 341 | 341 |
| 2021 3 | 0 | 221 | 221 |
| 2021 2 | 0 | 163 | 163 |
| 2020 1 | 0 | 126 | 126 |
| 2020 12 | 0 | 147 | 147 |
| 2020 11 | 0 | 137 | 137 |
| 2020 10 | 0 | 136 | 136 |
| 2020 9 | 0 | 152 | 152 |
| 2020 8 | 0 | 121 | 121 |
| 2020 7 | 0 | 129 | 129 |
| 2020 6 | 0 | 145 | 145 |
| 2020 5 | 0 | 181 | 181 |
| 2020 4 | 0 | 102 | 102 |
| 2020 3 | 0 | 111 | 111 |
| 2020 2 | 0 | 122 | 122 |
| 2020 1 | 0 | 107 | 107 |
| 2019 12 | 0 | 137 | 137 |
| 2019 11 | 0 | 133 | 133 |
| 2019 10 | 0 | 116 | 116 |
| 2019 9 | 0 | 190 | 190 |
| 2019 8 | 0 | 134 | 134 |
| 2019 7 | 0 | 172 | 172 |
| 2019 6 | 1 | 145 | 146 |
| 2019 5 | 0 | 200 | 200 |
| 2019 4 | 0 | 166 | 166 |
| 2019 3 | 0 | 74 | 74 |
| 2019 2 | 0 | 75 | 75 |
| 2019 1 | 0 | 52 | 52 |
| 2018 12 | 0 | 21 | 21 |
| 2018 11 | 4 | 28 | 32 |
| 2018 10 | 0 | 12 | 12 |
| 2018 9 | 0 | 21 | 21 |
| 2018 8 | 0 | 55 | 55 |
| 2018 7 | 0 | 50 | 50 |
| 2018 6 | 0 | 74 | 74 |
| 2018 5 | 0 | 123 | 123 |
| 2018 4 | 0 | 33 | 33 |
| 2018 3 | 37 | 15 | 52 |
| 2018 2 | 253 | 17 | 270 |
| 2018 1 | 259 | 18 | 277 |
| 2017 12 | 210 | 16 | 226 |
| 2017 11 | 281 | 17 | 298 |
| 2017 10 | 285 | 22 | 307 |
| 2017 9 | 253 | 9 | 262 |
| 2017 8 | 209 | 8 | 217 |
| 2017 7 | 228 | 12 | 240 |
| 2017 6 | 287 | 27 | 314 |
| 2017 5 | 318 | 15 | 333 |
| 2017 4 | 180 | 8 | 188 |
| 2017 3 | 370 | 32 | 402 |
| 2017 2 | 564 | 11 | 575 |
| 2016 1 | 205 | 9 | 214 |
| 2016 12 | 219 | 9 | 228 |
| 2016 11 | 342 | 20 | 362 |
| 2016 10 | 245 | 11 | 256 |
| 2016 9 | 328 | 21 | 349 |
| 2016 8 | 162 | 25 | 187 |
| 2016 7 | 67 | 11 | 78 |
| 2016 6 | 0 | 11 | 11 |
| 2016 5 | 0 | 5 | 5 |
| 2016 4 | 0 | 6 | 6 |
| 2016 3 | 0 | 3 | 3 |
| 2016 2 | 0 | 1 | 1 |
| 2015 1 | 1 | 7 | 8 |
| 2015 12 | 1 | 11 | 12 |
| 2015 11 | 0 | 1 | 1 |
| 2015 10 | 0 | 8 | 8 |
Mostrar todo
